diabetes mellitus, type 2

Showing NaN - NaN of 82

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetes, Type 2, Albuminuria Trial in Worldwide (Placebo, Canagliflozin, 100 mg, Canagliflozin, 300 mg)

Completed
  • Diabetes Mellitus, Type 2
  • Albuminuria
  • Placebo
  • +2 more
  • Little Rock, Arkansas
  • +353 more
Nov 19, 2018

Diabetes, Type 2, Cardiovascular Diseases, Risk Factors Trial in Worldwide (Placebo, Canagliflozin (JNJ-28431754) 100 mg,

Completed
  • Diabetes Mellitus, Type 2
  • +2 more
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +312 more
Nov 5, 2018

Diabetes, Type 2, PreDiabetes, Diet Habit Trial in Barcelona (Sardine, Control)

Completed
  • Diabetes Mellitus, Type 2
  • +4 more
  • Sardine
  • Control
  • Barcelona, Spain
    Diana A Diaz Rizzolo
Jul 18, 2018

Diabetes, Type 2 Trial in Worldwide (, linagliptin)

Completed
  • Diabetes Mellitus, Type 2
  • Sheffield, Alabama
  • +144 more
Jun 1, 2018

Diabetes, Type 2 Trial in Worldwide (LY2605541, Insulin Glargine, Insulin Lispro)

Completed
  • Diabetes Mellitus, Type 2
  • Mobile, Alabama
  • +155 more
Mar 16, 2018

Diabetes, Type 2 Trial in Worldwide (Insulin Pump (Medtronic Minimed Paradigm® VEO))

Completed
  • Diabetes Mellitus, Type 2
  • Insulin Pump (Medtronic Minimed Paradigm® VEO)
  • Atlanta, Georgia
  • +35 more
Feb 6, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • +2 more
  • Alexander City, Alabama
  • +135 more
Mar 8, 2017

Diabetes, Type 2 Trial in Worldwide (Rosiglitazone, Sulfonylurea, Metformin)

Completed
  • Diabetes Mellitus, Type 2
  • Miranda, New South Wales, Australia
  • +446 more
Mar 21, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/insulin aspart, biphasic insulin aspart, metformin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/insulin aspart
  • +2 more
  • Helsinki, Finland
  • +30 more
Feb 9, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, sitagliptin, metformin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +165 more
Jan 25, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, metformin, glimepiride)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Ciudad Autonoma de Bs As, Argentina
  • +189 more
Jan 24, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (rosiglitazone, inhaled human insulin, metformin)

Terminated
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Ebreichsdorf, Austria
  • +73 more
Feb 28, 2017

Diabetes, Diabetes, Type 2 Trial in Spain (metformin, repaglinide)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Barcelona, Spain
  • +17 more
Feb 17, 2017

Diabetes, Type 2 Trial in Worldwide (Dapagliflozin, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Mesa, Arizona
  • +95 more
Dec 20, 2016

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin detemir, insulin NPH)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin detemir
  • insulin NPH
  • Birmingham, Alabama
  • +95 more
Jan 27, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, insulin glargine, metformin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Bahía Blanca, Argentina
  • +115 more
Jan 25, 2017

Diabetes, Type 2 Trial in Worldwide (albiglutide + insulin glargine, insulin glargine + preprandial lispro insulin)

Completed
  • Diabetes Mellitus, Type 2
  • albiglutide + insulin glargine
  • insulin glargine + preprandial lispro insulin
  • Birmingham, Alabama
  • +209 more
Nov 21, 2016

Diabetes, Type 2 Trial in Worldwide ( to match albiglutide, albiglutide, metformin)

Completed
  • Diabetes Mellitus, Type 2
  • placebo to match albiglutide
  • +5 more
  • Alabaster, Alabama
  • +357 more
Nov 18, 2016

Diabetes, Type 2 Trial in Worldwide (albiglutide, sitagliptin, glimepiride)

Completed
  • Diabetes Mellitus, Type 2
  • albiglutide
  • +6 more
  • Birmingham, Alabama
  • +385 more
Nov 18, 2016

Diabetes, Type 2 Trial in Worldwide (Lixisenatide (AVE0010), Placebo, Pen auto-injector)

Completed
  • Diabetes Mellitus, Type 2
  • Lixisenatide (AVE0010)
  • +3 more
  • Bridgewater, New Jersey
  • +15 more
Oct 24, 2016

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/insulin aspart, insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/insulin aspart
  • insulin glargine
  • Birmingham, Alabama
  • +91 more
Oct 26, 2016

Diabetes, Type 2 Trial in Worldwide (Lixisenatide (AVE0010), Pen auto-injector, Exenatide)

Completed
  • Diabetes Mellitus, Type 2
  • Lixisenatide (AVE0010)
  • +4 more
  • Bridgewater, New Jersey
  • +17 more
Oct 20, 2016

Diabetes, Type 2 Trial in Worldwide (BI 10773, Glimepiride, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • BI 10773
  • +2 more
  • Phoenix, Arizona
  • +181 more
Jul 28, 2016

Diabetes, Type 2 Trial in Worldwide (Rosiglitazone/metformin)

Completed
  • Diabetes Mellitus, Type 2
  • Vienna, Austria
  • +92 more
Aug 31, 2016